Council membership key part of Company’s 2020-21 Canadian cannabis strategy
Vancouver, British Columbia, Canada – TheNewswire - August 12, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP) (CNSX:APP.CN) (FSE:2FA) (OTC:FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced today that it has accepted an invitation from the Canadian Chamber of Commerce to join the National Cannabis Working Group and the International Cannabis Council.
The National Cannabis Working Group (NCWG), launched in June 2019 consists of Canadian Chamber of Commerce members, including licensed cannabis cultivators, processors, retailers, and industry associations. With seventy (70) members of Canada’s leading leading publicly traded cannabis companies involved in all aspects of the supply chain such as production, processing, and retail, the NCWG advocates for public cannabis policies that foster a strong, competitive economic environment. As part of its membership GCAC will participate in activities such as consultations for Health Canada.
The International Cannabis Council (ICC) is a dedicated entity of the NCWG, which focuses on leveraging the Canadian Chamber’s work and bilateral cooperation with like-minded trade organizations worldwide. The Company’s participation in the council provides it access to the Business at OECD (BIAC) . The OECD (Organization for Economic Co-operation and Development) is an intergovernmental economic organization with 38 member countries.
GCAC’s CEO, Brad Moore, will take seats on both the NCWG and the International Cannabis Council. Moore has long been a proponent for the expanded use of medical cannabis based on a data driven model, as described in the Company’s patent pending Pain to Strain model and encapsulated in its Efixii blockchain software solution. As part of their go-to market strategy in Canada, GCAC recently announced ‘GCAC Funding Cannabis Cultivators That License Efixii’  and ‘GCAC Announces Medical Cannabis Sales License and Shop Update’ .
States Moore, “This opportunity will not only showcase the value of using truthful cannabis efficacy data when cannabis companies license our Efixii technology but also act as a resource for regulators and medical professionals across the globe. This invitation is a further endorsement of what GCAC has always held as our core vision-better outcomes for medical cannabis patients.”
About Global Cannabis Applications Corp. “GCAC”
GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.
Phone: +1 (800) 409-5679
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Copyright (c) 2021 TheNewswire - All rights reserved.